BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 24306668)

  • 1. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
    Choi ES; Kim HS; Han I
    Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
    Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
    Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma.
    Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
    J Surg Oncol; 2013 Dec; 108(7):481-5. PubMed ID: 24018883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
    Li Y; Liu X; Zhang J; Yao W
    Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
    Strojnik T; Smigoc T; Lah TT
    Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
    Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
    Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.
    Rossi L; Santoni M; Crabb SJ; Scarpi E; Burattini L; Chau C; Bianchi E; Savini A; Burgio SL; Conti A; Conteduca V; Cascinu S; De Giorgi U
    Ann Surg Oncol; 2015 Apr; 22(4):1377-84. PubMed ID: 25234022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
    Bień E; Balcerska A
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer.
    Seong MK
    J Korean Med Sci; 2015 Dec; 30(12):1793-9. PubMed ID: 26713054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer].
    Wang X; Li K
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):298-302. PubMed ID: 24989918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma.
    Nakamura T; Grimer R; Gaston C; Francis M; Charman J; Graunt P; Uchida A; Sudo A; Jeys L
    Eur J Cancer; 2013 Jan; 49(2):377-85. PubMed ID: 23058786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
    Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
    Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer.
    Tomita M; Shimizu T; Ayabe T; Nakamura K; Onitsuka T
    Anticancer Res; 2012 Aug; 32(8):3535-8. PubMed ID: 22843942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma.
    Fang HY; Huang XY; Chien HT; Chang JT; Liao CT; Huang JJ; Wei FC; Wang HM; Chen IH; Kang CJ; Huang SF
    Laryngoscope; 2013 Nov; 123(11):2690-9. PubMed ID: 23619955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
    Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
    BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USE OF NEUTROPHILS TO LYMPHOCYTES RATIO AS AN INFLAMMATION MARKER IN PATIENTS WITH CHRONIC TONSILLITIS.
    Sahin C; Varim C; Uyanık M
    Georgian Med News; 2016 Oct; (259):62-65. PubMed ID: 27845289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
    Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
    Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.